|
Feb 17
|
Why Eli Lilly and Company (LLY) Is the Best Drug Stock to Buy Now
|
|
Feb 16
|
2 Important Insights From Novo Nordisk's Earnings Call
|
|
Feb 15
|
Think Eli Lilly's Stock Is Expensive? Here's Why Selling It Now Could Be a Huge Mistake
|
|
Feb 14
|
Steve Mandel's Strategic Moves: A Closer Look at Eli Lilly and Co's 4.49% Portfolio Impact
|
|
Feb 14
|
Top Stock Reports for Apple, Eli Lilly & Shopify
|
|
Feb 14
|
Moderna's Q4 loss: Can the pharma giant get to profitability?
|
|
Feb 14
|
Novo Nordisk Beat Expectations in Q4 and a Huge Catalyst Could Be Coming Soon
|
|
Feb 13
|
Hims & Hers stock sees another spike in trading days after Super Bowl ad
|
|
Feb 13
|
Is Eli Lilly and Company (LLY) the Best Large Cap Dividend Growth Stock to Buy Now?
|
|
Feb 13
|
LLY Rises More Than 4% in a Week: How to Play the Stock
|
|
Feb 13
|
GLP-1 Drugs Drive Growth for Eli Lilly. Is the Stock a Buy?
|
|
Feb 12
|
Eli Lilly and Company's (NYSE:LLY) large institutional owners must be happy as stock continues to impress, up 4.7% over the past week
|
|
Feb 12
|
Why Eli Lilly and Company (LLY) is the Best Long-Term Growth Stock to Buy Now
|
|
Feb 12
|
Why the 'best hedge' against the AI rally losing steam in 2025 is healthcare: Morning Brief
|
|
Feb 11
|
Eli Lilly and Company (LLY): A Bull Case Theory
|
|
Feb 11
|
Jim Cramer Backs Eli Lilly (LLY): Will Its Drug Pipeline Dominate Pharma?
|
|
Feb 11
|
Eli Lilly pledges $630m on OliX’s Phase I RNA candidate for MASH
|
|
Feb 11
|
Merck KGaA pursuing Springworks; BridgeBio wins EU drug OK
|
|
Feb 10
|
Eli Lilly (LLY) Expands AdvanCell Partnership for Cutting-Edge Cancer Therapies
|
|
Feb 10
|
PRIMECAP Management's Strategic Moves: A Closer Look at Eli Lilly and Co
|